Federica Genovese, Ahmad Akhgar, Sung Sam Lim, Alton B Farris, Monica Battle, Jason Cobb, Dominic Sinibaldi, Morten A Karsdal, Wendy I White
Kidney360 2021 Sep 30Lupus nephritis (LN) occurs in <40% of patients with SLE. Reliable biomarkers of kidney damage are needed to identify patients with SLE at risk of developing LN to improve screening, treat the disease earlier, and halt progression to kidney failure. Novel biomarkers of extracellular matrix remodeling were evaluated as markers of kidney fibrosis and disease activity in patients with LN. Biomarkers of the interstitial collagen type III (PRO-C3) and type VI (PRO-C6) formation and of collagen type III (C3M) degradation were evaluated in the serum and urine of 40 patients with LN, 20 patients with SLE but without LN, 20 healthy controls, and ten biopsy controls (histologic kidney inflammation/damage without SLE). Their association with histologic markers of interstitial fibrosis and tubular atrophy, with inflammatory cell infiltration and with disease activity and chronicity in the patients with LN was assessed. Despite PRO-C3 (serum) and PRO-C6 (serum and urine) being significantly elevated in patients with LN compared with healthy controls, the markers did not differentiate patients with LN from those with SLE. C3M (urine) levels were not different in LN compared with the other groups. C3M (urine) strongly correlated and PRO-C6 (serum and urine) inversely correlated with kidney function (eGFR). The biomarkers of interstitial collagen turnover PRO-C6 (serum) and C3M (urine) correlated with histologic markers of interstitial fibrosis, tubular atrophy, and monocyte infiltration. Noninvasive collagen turnover biomarkers are promising tools to identify patients with SLE with kidney histologic modifications. Copyright © 2021 by the American Society of Nephrology.
Federica Genovese, Ahmad Akhgar, Sung Sam Lim, Alton B Farris, Monica Battle, Jason Cobb, Dominic Sinibaldi, Morten A Karsdal, Wendy I White. Collagen Type III and VI Remodeling Biomarkers Are Associated with Kidney Fibrosis in Lupus Nephritis. Kidney360. 2021 Sep 30;2(9):1473-1481
PMID: 35373114
View Full Text